The Parkinson's Disease Foundation has awarded over $1 million to 11 innovative researcher-initiated projects focused on understanding the cause and finding a cure for Parkinson's. These projects range from basic science investigations to potential new therapies, including studies of norepinephrine's role in the disease.
The Parkinson's Disease Foundation has announced $1.2 million in research awards to support scientists studying the cause of and potential treatments for Parkinson's disease. Funding will go towards projects exploring dopamine regulation, tobacco compounds, and more.
The Parkinson's Disease Foundation has awarded $300,000 in emergency bridge funding to four leading scientists working on novel research projects. The grants will support studies focused on improving gastrointestinal motility and targeting alpha-synuclein protein misfolding, among others.
The Parkinson's Disease Foundation has awarded $150,000 to study the potential of individualized stem cell therapy for treating Parkinson's disease. Researchers will investigate using transformed adult skin cells to replace damaged dopamine neurons in the brains of people with Parkinson's.
The Parkinson's Disease Foundation has awarded $950,000 in seed grants to 19 researchers, including Matthew Goldberg and Sandra M. Lynch, to explore new treatments for Parkinson's disease. The funding will support the development of animal models and antibody-based therapies.
The Parkinson Study Group has received a $200,000 grant from the Parkinson's Disease Foundation to fund innovative programs supporting clinical research. The grant will support retrospective data-mining projects and mentorship for young researchers, aiming to accelerate treatment development.
Researchers can submit study information to a new patient website, www.PDtrials.org, designed to improve access to Parkinson's clinical trial information. The site currently lists over 30 studies recruiting patients in the US and aims to educate patient communities on the value of clinical research.